Zikani Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$25.6M
- Investors
-
1
Zikani Therapeutics General Information
Description
Developer of ribosome-modulating agents designed to improve the lives of patients suffering from serious infections. The company's antibiotic compounds harness the power of synthetic chemistry and microbiology used in the treatment of serious, multi-drug resistant gram-negative infections, thereby enabling patients to recover quickly from multiple infection conditions.
Contact Information
Website
www.zikani.comCorporate Office
- 480 Arsenal Way
- Suite 130
- Watertown, MA 02472
- United States
Corporate Office
- 480 Arsenal Way
- Suite 130
- Watertown, MA 02472
- United States
Zikani Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Apr-2021 | $25.6M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series A1) | 09-Apr-2020 | Completed | Clinical Trials - General | |||
| 5. Early Stage VC (Series A) | 02-Apr-2018 | Completed | Startup | |||
| 4. Grant | 26-Mar-2018 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 25-Feb-2015 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Zikani Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Zikani Therapeutics Comparisons
Industry
Financing
Details
Zikani Therapeutics Competitors (36)
One of Zikani Therapeutics’s 36 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Visterra | Venture Capital-Backed | Waltham, MA | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Melinta Therapeutics | Private Equity-Backed | Parsippany, NJ | ||||
| InCarda Therapeutics | Venture Capital-Backed | West Jordan, UT |
Zikani Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zikani Therapeutics Patents
Zikani Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023334725-A1 | Treatment of familial adenomatous polyopsis using a 13-membered macrolide | Pending | 01-Sep-2022 | ||
| EP-4580639-A1 | Treatment of familial adenomatous polyopsis using a 13-membered macrolide | Pending | 01-Sep-2022 | ||
| WO-2024049994-A1 | Treatment of familial adenomatous polyopsis using a 13-membered macrolide | Inactive | 01-Sep-2022 | ||
| EP-4568747-A2 | Synthetic processes and intermediates for preparing therapeutic azaketolides | Pending | 11-Aug-2022 | ||
| US-20260049098-A1 | Synthetic processes and intermediates for preparing therapeutic azaketolides | Pending | 11-Aug-2022 | C07H17/08 |
Zikani Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zikani Therapeutics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advent Life Sciences | Venture Capital | Minority | ||
| Blavatnik Biomedical Accelerator | Accelerator/Incubator | Minority | ||
| CARB-X | University | |||
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| Roche Venture Fund | Corporate Venture Capital | Minority |
Zikani Therapeutics FAQs
-
When was Zikani Therapeutics founded?
Zikani Therapeutics was founded in 2015.
-
Where is Zikani Therapeutics headquartered?
Zikani Therapeutics is headquartered in Watertown, MA.
-
What is the size of Zikani Therapeutics?
Zikani Therapeutics has 17 total employees.
-
What industry is Zikani Therapeutics in?
Zikani Therapeutics’s primary industry is Biotechnology.
-
Is Zikani Therapeutics a private or public company?
Zikani Therapeutics is a Private company.
-
What is the current valuation of Zikani Therapeutics?
The current valuation of Zikani Therapeutics is .
-
What is Zikani Therapeutics’s current revenue?
The current revenue for Zikani Therapeutics is .
-
How much funding has Zikani Therapeutics raised over time?
Zikani Therapeutics has raised $49.8M.
-
Who are Zikani Therapeutics’s investors?
Advent Life Sciences, Blavatnik Biomedical Accelerator, CARB-X, Novartis Venture Fund, and Roche Venture Fund are 5 of 6 investors who have invested in Zikani Therapeutics.
-
Who are Zikani Therapeutics’s competitors?
Inovio Pharmaceuticals, Visterra, Cellaion, Melinta Therapeutics, and InCarda Therapeutics are some of the 36 competitors of Zikani Therapeutics.
-
When was Zikani Therapeutics acquired?
Zikani Therapeutics was acquired on 01-Apr-2021.
-
Who acquired Zikani Therapeutics?
Zikani Therapeutics was acquired by Eloxx Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
